Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAGOH3P (mago homolog 3, pseudogene) is a human pseudogene, meaning it resembles a protein-coding gene but is not believed to produce a functional protein product; it is not considered a therapeutic target and is not categorized as a known receptor, enzyme, transporter, or transcription factor[1][2][3][5]. There is no established biological function, disease association, or direct role in therapeutic intervention for MAGOH3P based on current public databases[3][6]. Key clarifications: - MAGOH3P is classified as a pseudogene by the HUGO Gene Nomenclature Committee and other genomic databases, indicating it is not an active, functional gene corresponding to a therapeutic target protein[1][5]. - It has no recognized role in disease biology, no interacting drugs, and is not targeted for therapeutic intervention[3][6]. - The entry is "incorrect" in the context of classical drug discovery and target validation because pseudogenes like MAGOH3P do not encode functional targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mago homolog 3, pseudogene (MAGOH3P).